bodyType

customContents

entityId

entityUuid

articlePageQuery

filter

article

articleBaseAdvertisingInfoArticle

articleListArticle

articleSeoArticle

helpersCheckIsPostiesArticle

hooksArticleAcknowledgementGateOverlayArticle

hooksTrackPageViewArticle

hooksContentInterestArticle

articleLinkingDataContent

articleSchemaContent

liveArticle

advertZone

sentiment

contentLock

topics

types

sections

moreOnThisArticles

urlAlias

commentCount

sponsorType

authorLocations

authors

paywallTypes

corrections

displaySlideShow

multimediaEmbed

printHeadline

seriesContainer

socialHeadline

headline

flag

firstTopic

glossary

flattenTypeIds

publishedDate

additionalInfoBoxes

images

image

relatedLinks

relatedNewsletters

__typename

createdDate

sponsor

factSheets

series

disableOffPlatformContent

published

updatedDate

summary

subHeadline

body

keywords

copyrighted

customTimezone

liveContents

Holly Chik

Blood thinners could improve the survival rate among the most severely ill Covid-19 patients, according to a hospital study in New York City.
The finding comes as doctors have been observing blood clot disorders among coronavirus patients that can damage vital organs.
The researchers found that intubated patients treated with anticoagulants – medicines that help prevent blood clots – had a mortality rate of 29 per cent.
Of those who were not treated with blood thinners, 63 per cent died.
And among the ventilated patients who did not survive, those on anticoagulants died after 21 days, while those not given the medicine died after nine days, the researchers said.
“Our findings suggest that systemic anticoagulation may be associated with improved outcomes among patients hospitalised with Covid-19,” they wrote in a peer-reviewed paper published in the Journal of the American College of Cardiology on May 6.


The study analysed 786 cases where patients had been given blood thinners – about 30 per cent of all Covid-19 patients admitted to five hospitals in the Mount Sinai Health System in New York City between mid-March and April. They were given the medicine orally and via injection under the skin or into a vein, the study said.
The researchers also noted that “patients who received anticoagulation were more likely to require invasive mechanical ventilation”.
Doctors amputated actor’s leg. What’s the coronavirus link?
Those who received a blood thinner before they were put on a ventilator had an in-hospital mortality rate of 22.5 per cent, compared to 22.8 per cent for those not given the medicine.
But the patients on blood thinners survived for longer – the median was 21 days, compared to 14 days for those who did not get them.
However, the researchers said the potential benefits of using anticoagulants “need to be weighed against the risk of bleeding and therefore should be individualised”.


According to the study, 38 patients not given anticoagulants had bleeding events – meaning they needed at least two units of red blood cell transfusion within 48 hours.
They were experienced by 24 of the patients on blood thinners – and of those, 15 had bleeding events after taking the medicine, and nine before.
Bleeding events were also more common among intubated patients than non-intubated.
“These data, derived from a large United States cohort, provide clinical insights for consideration in the management of patients hospitalised with Covid-19,” according to the paper.
“Prospective randomised trials are needed to determine whether systemic anticoagulation confers a survival benefit in hospitalised patients with Covid-19.”


A study in Britain has also suggested blood thinners could help some of the sickest patients. Researchers found that ischaemic stroke – which happens when an artery to the brain is clogged – linked to Covid-19 could occur when there is an abnormality of blood coagulation.
They concluded that “early therapeutic anticoagulation with [low molecular weight heparins – a blood thinner] could also be beneficial to reduce thromboembolism in patients with Covid-19-associated ischaemic stroke but must be balanced against the risk of intracranial haemorrhage”, or acute bleeding in the skull or brain which can be life-threatening.
“Clinical trials are warranted to determine the safety and efficacy of this approach,” the researchers said in a peer-reviewed paper published in the Journal of Neurology, Neurosurgery and Psychiatry on April 30.



How long Covid still keeps lives on hold 5 years after the pandemic began

Canada’s finance minister quits as unpopular Trudeau faces biggest test of political career

Xi puts faith in Lee to deliver on Hong Kong economic development, reform

China’s dwindling Western expat workforce should be cause for concern

Coronavirus pandemic

Blood thinners may help sickest Covid-19 patients survive, US study finds

An electron micrograph shows a cell infected with coronavirus particles. A new study has found blood thinners could benefit the most severely ill patients. Photo: EPA-EFE

Coronavirus: from ‘Covid toe’ to brain death, blood clots could be the real Covid-19 killer

Gravediggers carry the casket of someone presumed to have died from Covid-19 at a cemetery in the Staten Island borough of New York. Photo: AP

This handout image obtained on April 29, 2020 and released by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), shows a colorized scanning electron micrograph of an apoptotic cell (red) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. - The US intelligence community said Thursday it had concluded that the novel coronavirus that has swept the globe originated in China but was not man-made or engineered. (Photo by Handout / National Institute of Allergy and Infectious Diseases / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO / NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIH " - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS

FILE PHOTO: Soldiers are quarantined while recovering from the Spanish flu at Camp Funston, Kansas, U.S. in 1918. U.S. Army/Handout via REUTERS. THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY./File Photo

Nurse Jeanette Averett comforts a 56-year-old woman suffering from COVID-19 who was struggling with anxiety because of her non-invasive ventilator at Roseland Community Hospital in Chicago, Tuesday, April 28, 2020. (Ashlee Rezin Garcia/Chicago Sun-Times via AP)

Compound in licorice extract has potential to treat coronavirus, Chinese study finds

Chinese licorice contains a compound called liquiritin that could be a candidate for treating Covid-19. Photo: Shutterstock

SHUTTERSTOCK IMAGERoyalty-free stock photo ID: 1371856622Slice Licorice roots on sale

US coronavirus study says suppressing body’s initial immune response may help in fight against Covid-19

Researchers in the US have put forward a “counterintuitive” idea for treating Covid-19. Photo: Xinhua

In this Feb. 13, 2020, photo, a doctor checks the conditions of a patient in Jinyintan Hospital, designated for critical COVID-19 patients, in Wuhan in central China's Hubei province Top Chinese officials secretly determined they were likely facing a pandemic from a novel coronavirus in mid-January, ordering preparations even as they downplayed it in public. Internal documents obtained by the AP show that because warnings were muffled inside China, it took a confirmed case in Thailand to jolt Beijing into recognizing the possible pandemic before them. (Chinatopix Via AP)

News

China

Science

Coronavirus

Greater China

Health & Medicine


Researchers looked at cases where anticoagulants had been given in New York City hospitals
Of those on ventilators, patients given the medicine had a 29 per cent mortality rate. But it was 63 per cent for those who didn’t get blood thinners



Researchers looked at cases where anticoagulants had been given in New York City hospitals.


Blood thinners may help sickest Covid-19 patients survive, US study finds

Researchers looked at cases where anticoagulants had been given in New York City hospitals Of those on ventilators, patients given the medicine had a 29 per cent mortality rate. But it was 63 per cent for those who didn’t get blood thinners

Researchers looked at cases where anticoagulants had been given in New York City hospitals

Of those on ventilators, patients given the medicine had a 29 per cent mortality rate. But it was 63 per cent for those who didn’t get blood thinners